Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
DOWNLOAD WHITEPAPER

Polpharma Finished Dosage Formulation Dossier – Under Development

This white paper outlines Polpharma B2B's finished dosage formulations (FDF) that are currently under development.

Products listed include Esomeprazole powder for the treatment of peptic ulcers and gastro-oesophageal reflux disease, Orlistat anti-obesity capsules, Sitagliptin film-coated tablets for reducing blood glucose, and the Aciclovir antiviral tablets for systemic use.



Download to find out more.

DOWNLOAD

Submit

DOWNLOAD WHITEPAPER

Polpharma Finished Dosage Formulation Dossier – Under Development

This white paper outlines Polpharma B2B's finished dosage formulations (FDF) that are currently under development.

Products listed include Esomeprazole powder for the treatment of peptic ulcers and gastro-oesophageal reflux disease, Orlistat anti-obesity capsules, Sitagliptin film-coated tablets for reducing blood glucose, and the Aciclovir antiviral tablets for systemic use.



Download to find out more.

DOWNLOAD

We just need a few more details

If you would like to hear from carefully selected third party companies, check this box









Go Top